Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Con...

por Shiozawa, Aki, Hopson, Sari, Fuldeore, Rupali, Stoelzel, Matthias, Ng, Daniel, Hairston, John
Publicado 2020

Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA i...

por Kraus, Stephen R., Shiozawa, Aki, Szabo, Shelagh M., Qian, Christina, Rogula, Basia, Hairston, John
Publicado 2020

Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

por Carlson, Kevin V., Rovner, Eric S., Nair, Kavita V., Deal, Anna S., Kristy, Rita M., Hairston, John C.
Publicado 2021

Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study

por Burnett, Arthur L., Walker, David R., Feng, Qi, Johnston, Karissa M., Lozano‐Ortega, Greta, Nimke, David, Hairston, John C.
Publicado 2020

Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis

por Lozano-Ortega, Greta, Walker, David R., Johnston, Karissa, Mickle, Alexis, Harrigan, Sean, Rogula, Basia, Kristy, Rita M., Hairston, John C., Schermer, Carol R.
Publicado 2020

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

por Shore, Neal D., Renzulli, Joseph, Fleshner, Neil E., Hollowell, Courtney M. P., Vourganti, Srinivas, Silberstein, Jonathan, Siddiqui, Rizwan, Hairston, John, Elsouda, Dina, Russell, David, Cooperberg, Matthew R., Tomlins, Scott A.
Publicado 2022